Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 12;112(3):asaf029.
doi: 10.1093/biomet/asaf029. eCollection 2025.

A general form of covariate adjustment in clinical trials under covariate-adaptive randomization

Affiliations

A general form of covariate adjustment in clinical trials under covariate-adaptive randomization

Marlena S Bannick et al. Biometrika. .

Abstract

In randomized clinical trials, adjusting for baseline covariates can improve credibility and efficiency for demonstrating and quantifying treatment effects. This article studies the augmented inverse propensity weighted estimator, which is a general form of covariate adjustment that uses linear, generalized linear and nonparametric or machine learning models for the conditional mean of the response given covariates. Under covariate-adaptive randomization, we establish general theorems that show a complete picture of the asymptotic normality, efficiency gain and applicability of augmented inverse propensity weighted estimators. In particular, we provide for the first time a rigorous theoretical justification of using machine learning methods with cross-fitting for dependent data under covariate-adaptive randomization. Based on the general theorems, we offer insights on the conditions for guaranteed efficiency gain and universal applicability under different randomization schemes, which also motivate a joint calibration strategy using some constructed covariates after applying augmented inverse propensity weighted estimators.

Keywords: Augmentation; Covariate-adaptive randomization; G-computation; Model-assisted inference; Multiple treatment arms; Nonlinear adjustment.

PubMed Disclaimer

Similar articles

References

    1. Baldi Antognini A. & Zagoraiou M. (2015). On the almost sure convergence of adaptive allocation procedures. Bernoulli 21, 881–908.
    1. Chernozhukov V., Chetverikov D., Demirer M., Duflo E., Hansen C. & Newey W. (2017). Double/debiased/Neyman machine learning of treatment effects. Am. Econ. Rev. 107, 261–5.
    1. Cohen P. L. & Fogarty C. B. (2023). No-harm calibration for generalized Oaxaca–Blinder estimators. Biometrika 111, 331–8.
    1. Davies M. J., Russell-Jones D., Selam J.-L., Bailey T. S., Kerényi Z., Luo J., Bue-Valleskey J., Iványi T., Hartman M. L., Jacobson J. G. & Jacober S. J. (2016). Basal insulin peglispro versus insulin glargine in insulin-naïve type 2 diabetes: Imagine 2 randomized trial. Diabetes Obes. Metab. 18, 1055–64. - PMC - PubMed
    1. EMA (2015). Guideline on adjustment for baseline covariates in clinical trials. London, UK: European Medicines Agency [last accessed 24 September 2020].

LinkOut - more resources